The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureBertram Pitt, Janet Wittes, Faı̈ez Zannad et al.|New England Journal of Medicine|1999Cited by 9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCJohn J.V. McMurray, Stamatis Adamopoulos, Stefan D. Anker et al.|European Heart Journal|2012Cited by 6.9k
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureBertram Pitt, Janet Wittes, Faı̈ez Zannad et al.|Survey of Anesthesiology|2000Cited by 2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012John J.V. McMurray, Stamatis Adamopoulos, Stefan D. Anker et al.|European Journal of Heart Failure|2012Cited by 2.6k